perhexiline has been researched along with leptin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YE; Fan, Y; Garcia-Barrio, MT; Guo, Y; Li, L; Lomberk, GA; Mathison, AJ; Pennathur, S; Rader, DJ; Sun, L; Urrutia, R; Willer, CJ; Zeng, L; Zhang, J; Zhou, Z | 1 |
1 other study(ies) available for perhexiline and leptin
Article | Year |
---|---|
Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.
Topics: Animals; Apolipoprotein A-I; Apolipoproteins E; Atherosclerosis; Cholesterol; Cholesterol, HDL; Diet, Atherogenic; Drug Evaluation, Preclinical; Gene Expression Regulation; Genetic Therapy; Genetic Vectors; Genome-Wide Association Study; Hep G2 Cells; Humans; Hyperlipoproteinemia Type II; Kruppel-Like Transcription Factors; Leptin; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Perhexiline; Recombinant Fusion Proteins; RNA, Messenger; Sp Transcription Factors; Sterol Regulatory Element Binding Proteins | 2015 |